← Leaderboards
Brian Kevin Stansfield
Augusta University
$2,158,372
Attributed
$2,158,372
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $437.9K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,158,372 · 1
By mechanism
R01$2,158,372 · 1
Top collaborators
No co-investigators on record.
Most similar at Augusta University
Same institution · by research overlap
- Ruth B. Caldwell$11,181,117
- Balamurali K Ambati$10,199,905
- Menaka Chanu Thounaojam$1,307,625
- Modesto Antonio Rojas$593,863
- Qiuhua Yang$479,942
Others in their field
Other Emerging Leaders on “Early Detection Biomarkers”
- Bryan Faller · Decatur Memorial Hospital$26,356,185
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,144,108
- Michael P Harms · Washington University$13,645,932
- Leonard Freedman · Leidos Biomedical Research, Inc.$11,002,434
- Amit Singal · Ut Southwestern Medical Center$9,663,768
- Jessica Alber · University Of Rhode Island$8,348,817
Research focus
Early Detection BiomarkersEndothelial CellsAffect6-Phosphofructo-2-KinaseAcuteBevacizumabBiological MarkersBiological Models6-PhosphofructokinaseBlood VesselsCcl2 GeneCd14 GeneCell ProliferationChronicClinically RelevantClustered Regularly Interspaced Short Palindromic RepeatsCoculture TechniquesCognitiveBlood CapillariesCoupledCytokineDefined ContributionDependenceEnzymes
Grant awards (5)
Inflammation and retinopathy of prematurity$437,895
R01 · FY2023 · EY · contact PI
Inflammation and retinopathy of prematurity$424,755
R01 · FY2022 · EY · contact PI
Inflammation and retinopathy of prematurity$424,758
R01 · FY2021 · EY · contact PI
Inflammation and retinopathy of prematurity$437,206
R01 · FY2020 · EY · contact PI
Inflammation and retinopathy of prematurity$433,758
R01 · FY2019 · EY · contact PI